Search Results | MSF Science Portal

Journal Article

|

Letter

Mesic A, Decuyper I, Ishaq S, Azizi T, Hadi Ziamal F, et al.

2024-05-30 • European Respiratory Journal

Journal Article

|

Letter

Soares KA, Ehrlich J, Camara MS, Chaloub S, Emeka E, et al.

2023-10-01 • European Respiratory Journal

Journal Article

|

Commentary

Guglielmetti L, Huerga H, Khan UT, Varaine T

2020-03-01 • European Respiratory Journal

Journal Article

|

Letter

Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, et al.

2015-12-01 • European Respiratory Journal

Journal Article

|

Research

Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A, et al.

2020-03-20 • European Respiratory Journal

We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB): a sta...

Journal Article

|

Research

Orikiriza P, Smith JS, Ssekyanzi B, Nyehangane D, Mugisha IT, et al.

2021-06-17 • European Respiratory Journal

BACKGROUND
Non-sputum-based diagnostic approaches are crucial in children at high risk of disseminated tuberculosis (TB) who cannot expectorate sputum. We evaluated the diagnostic ac...

Journal Article

|

Research

Ndjeka N, Schnippel K, Master I, Meintjes GA, Maartens G, et al.

2018-10-25 • European Respiratory Journal

Background: South African patients with rifampicin-resistant tuberculosis and resistance to fluoroquinolones and/or injectables (pre/XDR-TB) were granted access to bedaquiline through a ...

Journal Article

|

Letter

Guglielmetti L, Varaine FFV, Huerga H, Bonnet MMB, Rich ML, et al.

2017-07-20 • European Respiratory Journal

Journal Article

|

Research

Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, et al.

2016-09-01 • European Respiratory Journal

Debate persists about monitoring method (culture or smear) and interval (monthly or less frequently) during treatment for multidrug-resistant tuberculosis (MDR-TB). We analysed existing ...

Journal Article

|

Letter

Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, et al.

2015-04-02 • European Respiratory Journal

Journal Article

|

Commentary

Brigden G, du Cros PAK, Wong S

2016-01-01 • European Respiratory Journal

Journal Article

|

Commentary

Lonnroth K, Migliori GB, Abubakar I, DAmbrosio L, de Vries G, et al.

2015-03-18 • European Respiratory Journal

This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework set...

Journal Article

|

Letter

Ndjeka N, Conradie F, Meintjes GA, Reuter A, Hughes J, et al.

2020-07-23 • European Respiratory Journal

Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralisation of services, the use of personal protective equipment, as well as strong partner...

Journal Article

|

Research

Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G, et al.

2018-05-03 • European Respiratory Journal

Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa. This was ...

Journal Article

|

Research

Chang EW, Page AL, Bonnet MMB

2015-12-02 • European Respiratory Journal

Light-emitting diode fluorescence microscopy (LED-FM) is recommended by the World Health Organization to replace conventional Ziehl–Neelsen microscopy for pulmonary tuberculosis ...

Journal Article

|

Letter

Berry C, Yates TA, Seddon JA, Phillips PPJ, du Cros PAK

2016-05-01 • European Respiratory Journal

Journal Article

|

Letter

Mohr-Holland E, Reuter A, Hughes J, Daniels J, Beko B, et al.

2020-07-01 • European Respiratory Journal

Journal Article

|

Letter

Kerkhoff AD, Sossen B, Schutz C, Reipold EI, Trollip AP, et al.

2019-11-07 • European Respiratory Journal

Journal Article

|

Editorial

Guglielmetti L, Varaine FFV

2021-06-10 • European Respiratory Journal

EXTRACT:
Bedaquiline can probably be considered the biggest breakthrough in tuberculosis drug development of the past decades. The first compound of a new anti-tuberculosis drug cl...

Journal Article

|

Research

Khan PY, Franke MF, Hewison CCH, Seung KJ, Huerga H, et al.

2021-06-17 • European Respiratory Journal

BACKGROUND
Recent World Health Organisation guidance on drug-resistant tuberculosis treatment de-prioritised injectable agents, in use for decades, and endorsed all-oral longer regim...

Science Portal

Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based non-randomized clinical trial, Kandahar Afghanistan

Implementation of WHO guidelines on urine lateral flow LAM testing in the high TB/HIV burden African countries

WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion?

Linezolid in drug-resistant tuberculosis: haste makes waste

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

Tuberculosis diagnostic accuracy of stool Xpert MTB/RIF and urine AlereLAM in vulnerable children

High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen

Shortened Multidrug-Resistant Tuberculosis Treatment in Settings with a High Prevalence of Ofloxacin Resistance

Multidrug-Resistant Tuberculosis Treatment Failure Detection Depends on Monitoring Interval and Microbiological Method

Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients

Barriers to New Drug Development in Respiratory Disease

Towards tuberculosis elimination: an action framework for low-incidence countries

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa

Light-emitting diode fluorescence microscopy for tuberculosis diagnosis: a meta-analysis

Efficacy, Safety and Tolerability of Linezolid for the Treatment of XDR-TB: a Study in China

Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa"

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV

The coming-of-age of bedaquiline: a tale with an open ending

All-oral longer regimens are effective for the management of multidrug resistant tuberculosis in high burden settings